Sign In
Buy PFE
$25.62
-0.420 (-1.61%)
At Close: Jun 08, 2026
FDA Panel to Discuss Fourth Booster Dose in April Meeting
01:11pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
The FDA advisory committee meeting on Apr 6 is likely to give an insight into how the regulatory agency feels about the need for additional boosters of COVID-19 vaccines.
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
12:31pm, Tuesday, 22'nd Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck's Keytruda Monotherapy Approved For A Type Of Endometrial Cancer
Merck & Co., Inc. (NYSE: MRK) s
Moderna (MRNA) Up on FDA Filing for Second COVID Booster Jab
06:30pm, Monday, 21'st Mar 2022 Zacks Investment Research
Moderna (MRNA) seeks the FDA's authorization for a fourth dose of its COVID vaccine in adults who already got an initial authorized booster dose of the same in the United States.
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
03:29pm, Monday, 21'st Mar 2022 Benzinga
After COVID-19 vaccine-induced strength, Moderna, Inc. (NASDAQ: MRNA) is on the lookout for the next big catalyst to boost its rangebound stock.
The Moderna Analyst: BofA Securities analyst Geoff M
The Zacks Analyst Blog Highlights J&J, Pfizer, BioNTech, and Moderna
10:49am, Monday, 21'st Mar 2022 Zacks Investment Research
J&J, Pfizer, BioNTech, and Moderna have been highlighted in this Analyst Blog.
2 Top Nasdaq Stocks to Buy on the Dip
10:15am, Monday, 21'st Mar 2022 The Motley Fool
Don't be too quick to abandon these companies.
3 Healthcare Stocks That Could Rise 28% or More, According to Wall Street
09:44am, Monday, 21'st Mar 2022 The Motley Fool
These former stock market darlings could recoup some of the heavy losses they recently suffered.
5 Unexpected Sources of Retirement Income
02:22pm, Sunday, 20'th Mar 2022 The Motley Fool
You're not stuck with just Social Security and your savings. See which of these strategies can generate more cash for you.
Will Pfizer Be a Trillion-Dollar Stock by 2040?
02:00pm, Sunday, 20'th Mar 2022 The Motley Fool
It may not be probable, but it's definitely possible.
3 Dividend Stocks That We'd Buy Without Any Hesitation
12:03pm, Sunday, 20'th Mar 2022 The Motley Fool
They all have attractive dividends and solid businesses.
Fully vaccinated will need fourth dose later this year, and new variant dubbed 'deltacron' detected in Europe
11:50am, Saturday, 19'th Mar 2022 MarketWatch
Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc., who said that COVID-19 is not going to just go away in the coming years.
What the Test to Treat Program Could Mean for Pfizer
11:01am, Saturday, 19'th Mar 2022 The Motley Fool
If the COVID-19 antiviral treatment sees high demand, it could be great for the pharmaceutical company's top line.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
10:05am, Saturday, 19'th Mar 2022 The Motley Fool
Voyager Therapeutics has promising technology. But the stock is very risky.
Moderna wants to offer all adults a second booster, and HHS chief laments lack of funding for Biden ‘test to treat’ strategy
04:30pm, Friday, 18'th Mar 2022 MarketWatch
Moderna Inc. has asked the U.S. Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster shot for all adults, a broader request than that made by Pfizer earlier thi
Why BioNTech Stock Is Jumping Today
03:38pm, Friday, 18'th Mar 2022 The Motley Fool
The momentum from earlier this week continues.
